Research Wilmot Scientists Aim at a Genetically Lethal Strain of Leukemia By Leslie Orr Jul. 16, 2015 Researchers at UR Medicine’s Wilmot Cancer Institute have developed what they believe to be the first mouse model to investigate why a certain subset of acute myeloid leukemia (AML) patients responds ...
Patient Care Wilmot Cancer Institute’s Blood and Marrow Transplant Program Receives Prestigious Accreditation By Ruth Harper-Rhode May. 4, 2015 The Blood and Marrow Transplant (BMT) Program at UR Medicine’s Wilmot Cancer Institute was recognized for its high level of care and detailed quality management processes with a three-year ...
Research Hematology Event Draws Wilmot Scientists, New Data By URMC Communications Dec. 5, 2013 Several members of the lymphoma and leukemia teams at the James P. Wilmot Cancer Center are to present research at the 55th annual American Society of Hematology (ASH) meeting, Dec. 7 to 10, which is ...
Research Lab Pinpoints New Drug Target for Infant Leukemia By URMC Communications Sep. 10, 2013 Although many childhood leukemias are curable, one type – known as 11q23 infant leukemia – has a poor survival rate and requires intensive treatment with life-threatening side effects. In an ...
Research Cancer Cell Metabolism Yields New Insights on Leukemia By Leslie Orr Jan. 17, 2013 University of Rochester Medical Center scientists have proposed a new reason why acute myeloid leukemia, one of the most aggressive cancers, is so difficult to cure.
Research URMC Finds Leukemia Cells Are “Bad to the Bone” By Leslie Orr Jan. 25, 2012 University of Rochester Medical Center researchers have discovered new links between leukemia cells and cells involved in bone formation, offering a fresh perspective on how the blood cancer ...
